95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Yoshie Hosaka1†
Yan Yan2†
Toshio Naito2,3*
Rieko Oyama3Koji Tsuchiya1
Norio Yamamoto4
Shuko Nojiri5
Satoshi Hori6Kazuhisa Takahashi3,7
Yoko Tabe1,3- 1Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
- 2Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
- 3Department of Research Support Utilizing Bioresource Bank, Juntendo University Faculty of Medicine, Tokyo, Japan
- 4Department of Microbiology, Tokai University School of Medicine, Hiratsuka, Kanagawa, Japan
- 5Medical Technology Innovation Center, Juntendo University Faculty of Medicine, Tokyo, Japan
- 6Infection Control Unit, Juntendo University Hospital, Tokyo, Japan
- 7Department of Respiratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
A Corrigendum on
SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge
Hosaka, Y., Yan, Y., Naito, T., Oyama, R., Tsuchiya, K., Yamamoto, N., Nojiri, S., Hori, S., Takahashi, K., and Tabe, Y. (2023). Front. Microbiol. 14:944369. doi: 10.3389/fmicb.2023.944369
In the published article, an author name was incorrectly written as Kazuhiko Takahashi. The correct spelling is Kazuhisa Takahashi.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: SARS-CoV-2, Delta variant, AY.29, immunosuppression, mutation, genome sequencing, nosocomial cluster
Citation: Hosaka Y, Yan Y, Naito T, Oyama R, Tsuchiya K, Yamamoto N, Nojiri S, Hori S, Takahashi K and Tabe Y (2024) Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge. Front. Microbiol. 15:1478638. doi: 10.3389/fmicb.2024.1478638
Received: 10 August 2024; Accepted: 12 August 2024;
Published: 23 August 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Hosaka, Yan, Naito, Oyama, Tsuchiya, Yamamoto, Nojiri, Hori, Takahashi and Tabe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Toshio Naito, bmFpdG9AanVudGVuZG8uYWMuanA=
†These authors have contributed equally to this work and share first authorship